Insider buying last 90 days
No open-market insider purchases were filed for HUM in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every HUM insider filing, plotted on the chart in Gekko.Open HUM in Gekko
Gekko Brief
AI summaryNov 4 closeHumana's week centers on expanded electronic prior authorization capabilities with athenahealth, now covering over 180,000 physicians and clinicians nationwide, aimed at reducing administrative burden and speeding patient access to care. Separately, Aaron Martin, President of Insurance at Humana, is set to join Intuitive Surgical's board effective 1 January 2027. Raymond James also added Humana to its healthcare stock selections, replacing UnitedHealth Group on that list.
Humana closed at $417.42, essentially flat on the day, with price sitting above both the 50-day average of $402.84 and the 200-day average of $310.44. One-month return stands at 3.3%, three-month at 13.7%, and one-year at 49.1%. The GekkoIndex reads 54.3, placing the stock in the Neutral zone, down 1.7 over five days. Gekko Fair Value is set at $536.03, leaving price 22.1% below that level.
Humana reports earnings on 6 November 2026, before the open, just one day away and within a typical 20-trading-day holding window; the prior quarter saw EPS of $7.61 against a $7.27 estimate, with a -5.7% reaction, and the company has beaten estimates in 7 of the last 8 quarters. Options activity shows 5 unusual signals over the past 30 days, with put premium of $9,269,415 against call premium of $3,124,905. Seasonality over the past 5 years shows average 20-day returns of 0.1% from this point, rising in 2 of those years. Analyst consensus stands at 12 buy and 4 hold ratings with a target of $465.12.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Humana price vs fair value
Close $417.42200-day averageGekko Fair Value $536.03
Humana quick facts
- Market cap
- $50.12B
- P/E ratio
- 39.2
- Forward P/E
- 26
- EPS, TTM
- $10.48
- Revenue, TTM
- $145.7B
- Profit margin
- 0.9%
- Dividend yield
- 0.85%
- Beta
- 0.64
- Volume
- 1.85M avg 1.56M
- 1-year return
- +49.1%
- Typical daily move
- ±3.4%
- Typical 20-day move
- ±6.4%
- 50-day average
- $402.84
- 200-day average
- $310.44
- Next earnings
- Nov 6 before open
- Shares outstanding
- 120.1M
Humana swing-trade checklist
Humana scores 2 supportive, 2 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $417.42 is above the 50-day ($402.84) and 200-day ($310.44) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
54.3, Neutral
Reading 54.3 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
22.1% below
Price is 22.1% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyheadwind
Leans bearish
Last 30 days: 5 unusual options signals.
See smart money - Earnings riskheadwind
Reports tomorrow
Reports on Nov 6, 2026, tomorrow — inside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+0.1% on average
From this point in the calendar, the next 20 trading days averaged +0.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Humana stock chart and price history
Humana closed at $417.42 on Nov 4, 2026, +49.1% over the past year, inside a 52-week range of $163.11 to $456.50.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +3.3%
- 3 months
- +13.7%
- 6 months
- +69.5%
- 1 year
- +49.1%
The full HUM chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HUM in Gekko
Follow Humana through every session
Put HUM on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track HUM in GekkoFree for 7 days. No credit card required.
About Humana
Humana provides health insurance and related benefits to individuals and groups throughout the United States, working through a network of subsidiary companies. It is known for offering medical coverage alongside supplemental products such as dental, vision, and other ancillary plans, serving consumers directly as well as employer groups.
The company organizes its work into three segments: Retail, Group and Specialty, and Healthcare Services. It contracts with government bodies, including an agreement with the Centers for Medicare and Medicaid Services to run the Limited Income Newly Eligible Transition prescription drug program, and it partners with various states to provide Medicaid, dual-eligible, and long-term care benefits. For employers, Humana offers fully insured commercial health coverage and administrative-services-only arrangements, and it supports military members through contracts such as TRICARE T2017 East Region. Its Healthcare Services segment extends beyond insurance into pharmacy management, provider network operations, and home-based care, serving both its own plan members and outside clients.
Humana is headquartered in Louisville, Kentucky, and was founded in 1961. Its shares are listed on the NYSE under the ticker HUM.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Managed health care
- Website
- humana.com
Humana GekkoIndex: the smart money zone
Humana’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.3, in the Neutral zone, down 1.7 points over five sessions.
54.3Neutral
Down 1.7 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 74 | −0.3% | −1.0% | ||
| Accumulation | 236 | +0.6% | +3.8% | ||
| Neutral (current zone) | 335 | −0.1% | −1.1% | ||
| Distribution | 50 | +1.4% | +8.5% | ||
| Selling | 2 | Too few readings yet | |||
Average HUM share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the HUM price, zone by zone.Track HUM in Gekko
Is Humana stock overvalued? Gekko Fair Value
Humana trades 22.1% below Gekko Fair Value of $536.03, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Humana shares are worth, recalculated every trading day.
$536.03
Gekko Fair Value, Nov 4, 2026
22.1% Undervalued
At the end of Aug 2026 the price was 27.8% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open HUM in Gekko
Humana insider and Congress trading
No open-market insider purchases were filed for Humana, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in HUM were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for HUM, plotted on the chart in Gekko.Open HUM in Gekko
Buybacks
Humana has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $1.00M
- As a share of market cap
- 0.00%
From company filings.
Unusual options activity last 30 days
5signals, 25% of the flagged premium in calls.
Latest: Bearish flow on Oct 28, $1.33M in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold HUM.
1added0opened1trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
Humana earnings: next date and track record
Humana reports on Nov 6, 2026, before the open (tomorrow), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 6, 2026
Expected before the open, tomorrow
- EPS estimate
- −$1.00
- Revenue estimate
- $40.87B
7 of 8reports beat the EPS estimate
±4%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 29, 2026 AI summary
- What they said
- Humana reported Q2 2026 results tracking to expectations, with 2026 member growth on track and new/returning membership performing as expected. Management emphasized progress toward a sustainable pretax margin of at least 3% by 2028. Stars program showed meaningful improvement, outpacing historical CAGR on 11 of 12 HEDIS and Patient Safety metrics for bonus year 2028. A virtual investor update is scheduled for December 10.
- Guidance
- Humana expects 2027 MA bid strategy to drive margin progression toward a 2028 sustainable pretax margin target of at least 3%. Margin expansion will be driven by clinical excellence, operating efficiency, and plan mix/benefit adjustments. Management reaffirmed Investor Day commitments.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $7.61 est $7.27 | $40.87B est $40.58B | −5.7% |
| Apr 29, 2026 | $10.31 est $10.20 | $39.65B est $39.37B | +2.9% |
| Feb 11, 2026 | −$3.96 est −$4.00 | $32.52B est $32.04B | −1.4% |
| Nov 5, 2025 | $3.24 est $2.93 | $32.65B est $32.00B | −10.9% |
| Jul 30, 2025 | $6.27 est $5.87 | $32.39B est $31.87B | +7.4% |
| Apr 30, 2025 | $11.58 est $10.07 | $32.11B est $32.20B | −1.3% |
| Feb 11, 2025 | −$2.16 est −$2.12 | $29.21B est $28.81B | −2.5% |
| Oct 30, 2024 | $4.16 est $3.39 | $29.40B est $28.68B | 0.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Humana stock forecast and analyst price targets
Analysts’ average 12-month price target for Humana is $465.12, +11.4% from the last close, from 16 firms rating the stock in the last 90 days.
$465.12consensus 12-month target, +11.4% from the last close
Now $417.42Avg $465.12
Low $393High $596
Each firm’s latest rating in the last 90 days: 16 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 20 | Guggenheim | $471 | +12.8% |
| Oct 14 | Barclays | $582 | +39.4% |
| Oct 13 | Mizuho Securities | $495 | +18.6% |
| Oct 13 | Evercore ISI | $480 | +15.0% |
| Oct 12 | Truist Financial | $475 | +13.8% |
−1.1%average 20-day move after past Neutral readings
+0.1%average move over the next 20 trading days in the last 5 years
±3.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Humana seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Humana averaged +0.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.1% | 2 of 5 |
| Next 10 trading days | −2.4% | 2 of 5 |
| Next 15 trading days | +0.4% | 2 of 5 |
| Next 20 trading days | +0.1% | 2 of 5 |
| Next 30 trading days | −5.7% | 0 of 5 |
For scale, HUM’s typical 20-trading-day move in either direction is about 6.4%.
Humana market cap and key statistics
Humana’s market cap is $50.12B, with a P/E ratio of 39.2 and revenue of $145.7B over the last twelve months.
Valuation
- Market cap
- $50.12B
- P/E ratio
- 39.2
- Forward P/E
- 26
- EPS, TTM
- $10.48
- Gekko Fair Value
- $536.03
Trading
- Volume
- 1.85M
- Avg volume, 20 days
- 1.56M
- 52-week high
- $456.50
- 52-week low
- $163.11
- Shares outstanding
- 120.1M
Financials
- Revenue, TTM
- $145.7B
- Profit margin
- 0.9%
- Return on equity
- 6.9%
- Quarterly earnings growth, YoY
- +27.1%
Risk and income
- Beta
- 0.64
- Typical daily move
- ±3.4%
- Typical 20-day move
- ±6.4%
- Dividend yield
- 0.85%
Humana stock news this week
Coverage of Humana this week reads positive: 9 positive, 6 neutral and 0 negative headlines.
- Are Investors Undervaluing Humana (HUM) Right Now?Zacks Investment Research, Nov 4
- Mirae Asset Global Investments Co. Ltd. Purchases 36,832 Shares of Humana Inc. $HUMMarketBeat, Nov 4
- Humana and athenahealth expand electronic prior authorization capabilities nationwide, reducing administrative burden for physicians and helping patients access care fasterStock Titan, Nov 3
- Sumitomo Mitsui Trust Group Inc. Sells 7,800 Shares of Humana Inc. $HUMMarketBeat, Nov 3
- Humana’s Aaron Martin is expected to join Intuitive Surgical (ISRG)’s board on Jan. 1, 2027.Stock Titan, Nov 2
- Intuitive adds Humana insurance president to boardInvesting.com, Nov 2
Humana peers
Humana’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| UNHUnitedHealth | Neutral | 9.7% above |
| ELVElevance Health | Neutral | 31.6% below |
| CICigna | Neutral | 33.1% below |
| CNCCentene | Neutral | 13.6% below |
| MOHMolina Healthcare | Neutral | 34.2% below |
| OSCROscar Health | Neutral | 4.8% above |
A peer links to its own page where one exists.
Humana stock FAQ
What is Humana’s market cap?
Humana’s market cap is $50.12B at the Nov 4, 2026 close of $417.42, with 120.1M shares outstanding. The shares trade on a P/E ratio of 39.2.
What is the Humana stock forecast?
The consensus analyst 12-month price target for Humana is $465.12, +11.4% from the last close. Of the 16 firms that rated the stock in the last 90 days, 12 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Humana stock overvalued or undervalued?
On Gekko’s estimate Humana is undervalued: the Nov 4, 2026 close of $417.42 is 22.1% below Gekko Fair Value of $536.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Humana report earnings next?
Humana is expected to report on Nov 6, 2026, before the market opens (tomorrow). Analysts expect earnings of −$1.00 per share on revenue of $40.87B. Humana beat the earnings estimate in 7 of its last 8 reports, moving 4% on average across the report.
What is Humana’s 52-week high and low?
Humana’s 52-week high is $456.50 and its 52-week low is $163.11; it closed at $417.42 on Nov 4, 2026, +49.1% over the past year. Over the last five years the shares peaked at $571.30 on Nov 3, 2022.
Is Humana stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 6 items with data read as supportive (trend and fair value), 2 as mixed (gekkoindex and seasonality) and 2 as headwinds (smart money and earnings risk). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in Humana?
Gekko flagged 5 unusual options signals in Humana over the last 30 days, with $3.12M of flagged premium in calls and $9.27M in puts. The latest, bearish flow, was on Oct 28, 2026 with $1.33M in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Humana the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.